<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id><journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id><journal-id journal-id-type="publisher-id">nss</journal-id><journal-title-group><journal-title>Nature and Science of Sleep</journal-title></journal-title-group><issn pub-type="epub">1179-1608</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39318395</article-id><article-id pub-id-type="pmc">11420893</article-id><article-id pub-id-type="publisher-id">468269</article-id><article-id pub-id-type="doi">10.2147/NSS.S468269</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>The Abnormal N-Acetylaspartate to Creatine Ratio of the Right Putamen is Linked to Wakefulness in Patients with Insomnia Disorder</article-title><alt-title alt-title-type="running-authors">Huang et al</alt-title><alt-title alt-title-type="running-title">Huang et al</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2362-920X</contrib-id><name><surname>Huang</surname><given-names>Qiaoting</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Shi</surname><given-names>Changzheng</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sonkusare</surname><given-names>Saurabh</given-names></name><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Congrui</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Voon</surname><given-names>Valerie</given-names></name><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="an0002" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Pan</surname><given-names>Jiyang</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="an0001" ref-type="corresp"/></contrib><aff id="aff0001"><label>1</label><institution>Department of Psychiatry, The First Affiliated Hospital of Jinan University</institution>, <addr-line>Guangzhou</addr-line>, <country>People’s Republic of China</country></aff><aff id="aff0002"><label>2</label><institution>Medical Imaging Center, The First Affiliated Hospital of Jinan University</institution>, <addr-line>Guangzhou</addr-line>, <country>People’s Republic of China</country></aff><aff id="aff0003"><label>3</label><institution>Department of Psychiatry, University of Cambridge</institution>, <addr-line>Cambridge</addr-line>, <country>UK</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: Jiyang Pan, <institution>Department of Psychiatry, The First Affiliated Hospital of Jinan University</institution>, <addr-line>613 West Huangpu Avenue</addr-line>, <addr-line>Guangzhou</addr-line>, <addr-line>510630</addr-line>, <country>People’s Republic of China</country>, <phone content-type="general">Tel +86 20 38688651</phone>, Email jiypan@163.com</corresp><corresp id="an0002">Valerie Voon, <institution>Department of Psychiatry, University of Cambridge</institution>, <addr-line>Box 189, Level E4, Addenbrooke’s Hospital</addr-line>, <addr-line>Cambridge</addr-line>, <addr-line>CB2 0QQ</addr-line>, <country>UK</country>, <phone content-type="general">Tel +44 1223 765088</phone>, Email vv247@cam.ac.uk</corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>16</volume><fpage>1407</fpage><lpage>1418</lpage><history><date date-type="received"><day>05</day><month>5</month><year>2024</year></date><date date-type="accepted"><day>03</day><month>9</month><year>2024</year></date></history><permissions><copyright-statement>© 2024 Huang et al.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Huang et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><abstract><sec><title>Purpose</title><p><citation_analysis attribute="positive">Converging evidence implicates the putamen in sleep-wake regulation. However, its role remains unclear. We hypothesized that metabolic abnormalities in the putamen are linked to insomnia disorder, which has not been previously addressed, and investigated putaminal N-acetylaspartate (NAA), choline (Cho), and creatine (Cr) in patients with insomnia disorder compared to healthy controls.</citation_analysis></p></sec><sec><title>Participants and Methods</title><p><citation_analysis attribute="positive">In the present study, the concentrations of NAA, Cho, and Cr in the putamen of 23 patients with insomnia disorder and 18 healthy controls were determined using proton magnetic resonance spectroscopy. Sociodemographic, psychometric, and polysomnography data were obtained from all participants.</citation_analysis></p></sec><sec><title>Results</title><p><citation_analysis attribute="positive">We found that the mean NAA/Cr ratio of the right putamen was significantly greater in the insomnia group compared to the control group and also greater than the left putamen within the insomnia group. The NAA/Cr ratio of the right putamen distinguished insomnia disorder from normal sleep with 78.3% sensitivity and 61.1% specificity. Furthermore, this ratio positively correlated with both objective and subjective insomnia severity and sleep quality.</citation_analysis></p></sec><sec><title>Conclusion</title><p><citation_analysis attribute="positive">Our findings provide critical evidence for the dysfunctional putaminal metabolism of NAA/Cr in insomnia disorder, suggesting that the abnormal NAA/Cr ratio of the right putamen is linked to wakefulness in patients with insomnia disorder and may serve as a potential biomarker of insomnia disorder.</citation_analysis></p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>insomnia disorder</kwd><kwd>wakefulness</kwd><kwd>putamen</kwd><kwd>proton magnetic resonance spectroscopy</kwd><kwd>NAA/Cr ratio</kwd><kwd>polysomnography</kwd></kwd-group><counts><fig-count count="3"/><table-count count="3"/><ref-count count="62"/><page-count count="12"/></counts></article-meta></front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Chronic insomnia is characterized as the dissatisfaction with the ability to initiate and maintain sleep and sleep duration and/or quality.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither"> It is one of the most common medical complaints with a high prevalence of 4%-50% globally.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1–5</xref></citation_analysis><citation_analysis attribute="positive"> Affected individuals experience significant distress and impaired daytime functioning and are prone to developing psychiatric and cardiovascular disorders, resulting in increased healthcare burden.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6–8</xref></citation_analysis><citation_analysis attribute="neither"> Despite the high prevalence and socioeconomic burden, the neurobiology of insomnia, especially the brain mechanisms of insomnia, has remained elusive, hampering the development of effective treatments.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0009" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">The putamen, as a key component of the striatum and a critical component of the fronto-striatal circuit that governs reward and motivation, is well recognized for its role in motor control and movement disorders.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11–14</xref></citation_analysis><citation_analysis attribute="positive"> However, emerging studies have focused on the role of the putamen in sleep-wake regulation. Firstly, the putamen has been shown to regulate arousal by inhibitory GABAergic projections to pallidum and thalamus, promoting cortical activity and wakefulness.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="neither"> Consistent with this, bilateral lesions of the putamen in rats reduced the time spent in wakefulness, and led to fragmentation of both sleep and wakefulness.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15–19</xref></citation_analysis><citation_analysis attribute="positive"> Secondly, morphometric studies in human studies show that insomnia is associated with altered anatomical measures of the putamen.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20–24</xref></citation_analysis><citation_analysis attribute="neither"> For instance, lower putaminal volume is associated with higher arousal indices measured by polysomnography in patients with chronic insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="positive"> Similarly, smaller volumes of the putamen and caudate have also been observed in psychophysiological and paradoxical insomnia patients, along with associations of both subjective and objective sleep parameters with the shape alterations of the putamen.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither"> In contrast, in healthy older adults, greater bilateral putaminal volumes correlated with greater insomnia severity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither"> Thirdly, studies suggest a functional role of the putamen associated with sleep parameters.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24–27</xref></citation_analysis><citation_analysis attribute="positive"> For example, using resting-state functional magnetic resonance imaging (fMRI), the area under the curve of the nodal betweenness centrality of the right putamen was found to be positively associated with the three-item sleep subscale on the Hamilton Depression Scale-17.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="positive"> In addition, using task-based fMRI with emotional stimuli, patients with chronic insomnia showed lower activation of the putamen, ventral striatum, right insula, orbitofrontal cortex and ventral tegmental area compared to healthy controls, which correlated with severity of insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="positive"> Similarly, emotional reactivity to positive stimuli (humorous films) in patients with insomnia also demonstrated a potential link of insomnia to putaminal activity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="neither"> Fourthly, the putamen shows abnormalities in connectivity with multiple brain regions linked to insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="positive"> By way of illustration, patients with insomnia disorder demonstrated decreased thalamic connectivity with the putamen across wakefulness and all three nonrapid eye movement sleep stages.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither"> Similarly, increased resting-state functional connectivity of the putamen with the nucleus accumbens was found in patients with insomnia disorder.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="neither"> Lastly, other relevant studies have also shed light on the link of putaminal function to sleep. Increased right putaminal activation was observed in subjects after total sleep deprivation, suggesting that arousal levels may be linked to putaminal activity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="neither"> Compared with the normal controls, increased phase shift values in the left putamen and left caudate were detected in patients with primary insomnia in an in vivo susceptibility‐weighted imaging study.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="neither"> Interestingly, as a manifestation of physiological arousal, restlessness has been linked to putaminal function, whereas motor regulation is linked to connectivity with the primary motor cortex and premotor areas.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Noteworthily, clinical evidence indirectly reflects the sleep-wake regulatory role of the putamen as well. Sleep disorders are highly common in patients with Parkinson’s disease characterized by loss of dopaminergic neurons in the dorsal striatum,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="neither"> with an estimated prevalence of 60%-80%.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0033" ref-type="bibr">33</xref></citation_analysis><citation_analysis attribute="neither"> Using [</citation_analysis><citation_analysis attribute="positive"><sup>11</sup></citation_analysis><citation_analysis attribute="neither">C]DASB positron emission tomography, Parkinson’s patients with sleep dysfunction showed decreased [</citation_analysis><citation_analysis attribute="positive"><sup>11</sup></citation_analysis><citation_analysis attribute="neither">C]DASB BP</citation_analysis><citation_analysis attribute="positive"><sub>ND</sub></citation_analysis><citation_analysis attribute="neither"> values in the putamen, caudate, ventral striatum, thalamus, hypothalamus, and raphe nuclei, compared to those without sleep dysfunction.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="neither"> Besides, in patients with Huntington’s disease, where the putamen can also become severely impaired, multiple sleep disturbances have been observed including increased sleep latency, frequent nocturnal awakenings, more time spent awake, reduced sleep efficiency and slow wave sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0035" ref-type="bibr">35</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Taken together, the above findings highlight the potential role of the putamen in the mechanisms of insomnia, although the findings are not always consistent with both increases and decreases in volume or connectivity, along with either positive or negative correlations with sleep parameters. Importantly, the role of metabolic function of the putamen in insomnia remains unclear.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Proton magnetic resonance spectroscopy (</citation_analysis><citation_analysis attribute="positive"><sup>1</sup></citation_analysis><citation_analysis attribute="neither">H-MRS) offers a noninvasive method to measure brain metabolism and neurochemistry.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="positive"> As measured using </citation_analysis><citation_analysis attribute="positive"><sup>1</sup></citation_analysis><citation_analysis attribute="neither">H-MRS, N-acetylaspartate (NAA, in which a decrease can reflect neuronal degeneration),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37–39</xref></citation_analysis><citation_analysis attribute="neither"> choline (Cho, which reflects non-specific cell membrane breakdown),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0040" ref-type="bibr">40</xref></citation_analysis><citation_analysis attribute="neither"> and creatine (Cr, whose content is relatively stable and not easily affected by various pathological conditions and often used as a reference to measure the content of other metabolites)</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0041" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither"> are common neurobiochemical metabolites used to assess disease status.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="positive"> Therefore, in order to further understand the role of the putamen in sleep-wake regulation, especially in insomnia disorder, we investigated putaminal metabolites in patients with insomnia disorder and healthy normal sleepers by utilizing 2D multi-voxel </citation_analysis><citation_analysis attribute="positive"><sup>1</sup></citation_analysis><citation_analysis attribute="neither">H-MRS. Specifically, we hypothesized that (1) NAA/Cr and/or Cho/Cr ratios of the bilateral or unilateral putamen in patients with insomnia disorder would differ from those in healthy normal sleepers, and the direction of this difference would reflect the pathophysiological significance of NAA, Cho, and Cr within the putamen in insomnia disorder; (2) there are close correlations between putaminal metabolites and sleep parameters; and (3) altered putaminal metabolites may be a potential biomarker of insomnia.</citation_analysis></p>
    </sec>
    <sec id="s0002">
      <title>Materials and Methods</title>
      <sec id="s0002-s2001">
        <title>Study Procedure and Participants</title>
        <p><citation_analysis attribute="positive">In the present study, right-handed participants were recruited through advertisements from community population and from outpatient units of the Department of Psychiatry, The First Affiliated Hospital of Jinan University, Guangzhou, China. As shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">Figure 1</xref></citation_analysis><citation_analysis attribute="positive">, patients with insomnia disorder (insomnia group) were selected from 195 individuals with insomnia complaints. Age-sex-education-nationality matched healthy normal sleepers (control group) were selected from 50 individuals without insomnia complaints and medical history who were willing to participate in the present study. All participants were evaluated with an unstructured clinical interview for history of medical and sleep disorders, and a structured interview for lifetime history of psychiatric disorders using the Mini-International Neuropsychiatric Interview (M.I.N.I).,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0042" ref-type="bibr">42</xref></citation_analysis><citation_analysis attribute="neither"> Chinese version.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="positive"> Insomnia disorder was diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria by a senior psychiatrist, based on participants’ primary complaints of sleep disturbance despite adequate opportunity for sleep, distresses or impairments of functioning caused by the sleep disturbance, and duration of the sleep difficulty. Meanwhile, it was required that the insomnia was not attributable to any coexisting mental disorder and medical condition, or the physiological effects of a substance.
</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p><citation_analysis attribute="neither">Recruitment flow chart of the subjects.</citation_analysis></p></caption><graphic xlink:href="NSS-16-1407-g0001" content-type="print-only" position="float"/><attrib><bold>Note</bold>: Diagnosis of insomnia disorder was made according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria by a senior psychiatrist.</attrib></fig></citation_analysis></p>
        <p><citation_analysis attribute="positive">The inclusion criteria of our study included (1) age ≥ 18 years and ≤ 60 years; (2) capability to complete psychometric assessments and polysomnography (PSG); (3) unmedicated condition (to avoid the potential effects of medication, we recruited only unmedicated participants); (4) no previous or current non-pharmacological treatment for insomnia disorder, such as cognitive-behavioral therapy, was received; (5) no shift work and no staying up late in last 3 months; (6) informed consent; and (7) a current diagnosis of DSM-5 primary insomnia disorder for the insomnia subjects; no sleep complaints for the control subjects. The exclusion criteria were as follows: (1) any other current psychiatric disorder (including substance abuse and dependence); (2) any current sleep disorder other than insomnia disorder; (3) known acute or chronic medical conditions; (4) a trans-meridian flight during the last three months; (5) use of medications or substances known to affect sleep or mood, or abnormal coffee and/or alcohol consumption; (6) known dementia or other cognitive impairment; and (7) pregnant and lactating women. Individuals who had abnormal sleep patterns were also excluded from the control group. In addition, participants with either an apnea-hypopnea index or a periodic limb movements of sleep index greater than 5 were excluded from the present study. For control subjects, a sleep efficiency greater than 90%, combined with a subjective report of sleep similar to usual, was required.</citation_analysis></p>
        <p><citation_analysis attribute="positive">All participants provided written informed consent before their participation in the study. This study was conducted in accordance with the Declaration of Helsinki and as per the protocol approved by the Human Research and Ethics Committee of The First Affiliated Hospital of Jinan University, Guangzhou, China (approval number: KY-2023-110).</citation_analysis></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Clinical Assessment Instruments</title>
        <sec id="s0002-s2002-s3001">
          <title>Sociodemographics</title>
          <p><citation_analysis attribute="positive">The weight and height of all subjects were measured and used to calculate body mass index (BMI). Other basic information, including age, sex, education level, occupation, smoking status, and alcohol intake, was measured using binary or ordinal questions.</citation_analysis></p>
        </sec>
        <sec id="s0002-s2002-s3002">
          <title>Psychometric Assessments</title>
          <p><citation_analysis attribute="neither">Assessments including the Chinese versions of the Pittsburgh Sleep Quality Index (PSQI),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0045" ref-type="bibr">45</xref></citation_analysis><citation_analysis attribute="neither"> Insomnia Severity Index (ISI),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0047" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="neither"> State-Trait Anxiety Inventory (STAI),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0048" ref-type="bibr">48</xref></citation_analysis><citation_analysis attribute="neither"> and Beck Depression Inventory, 2nd edition (BDI-II)</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0049" ref-type="bibr">49</xref></citation_analysis><citation_analysis attribute="neither"> were performed on all subjects.</citation_analysis></p>
        </sec>
      </sec>
      <sec id="s0002-s2003">
        <title>PSGs</title>
        <p><citation_analysis attribute="positive">All subjects underwent one night of in-laboratory PSG to eliminate first-night effects and to preliminarily screen them for potential sleep disorders, and one additional night for the assessment of sleep architectures, utilizing a dynamic 64-lead PSG device (Compumedics, Australia) with a continuous recording time of at least 8 hours.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither"> Subjects were instructed not to take stimulating substances and psychoactive substances, including nicotine, alcohol, and coffee and to abstain from high intensity exercise for 24 hours before the PSG measurements. Surface electrodes were used to record electroencephalograms, electrooculograms, electromyograms (EMG), and electrocardiograms. Apnea and hypopnea were monitored via oximetry, respiratory efforts (abdominal and thoracic efforts), nasal airflow, and nasal pressure. Periodic limb movements were monitored via EMG of the anterior tibialis. The sleep parameters of all the subjects were reviewed and confirmed by a skilled PSG technician.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2004">
        <title>Neuroimaging Data Acquisition and Analysis</title>
        <p><citation_analysis attribute="neither">The subjects were taken to the Medical Imaging Center for MRS acquisition on the second night before PSG recording. All subjects underwent </citation_analysis><citation_analysis attribute="positive"><sup>1</sup></citation_analysis><citation_analysis attribute="neither">H-MRS scans between 19:00–20:00 (ie, approximately 3 h before their usual bedtime).</citation_analysis></p>
        <sec id="s0002-s2004-s3001">
          <title>Data Acquisition</title>
          <p><citation_analysis attribute="neither">MRI/MRS data were acquired on a 3.0T MR scanner (Discovery MR 750, GE Healthcare, Milwaukee, WI, USA) with an eight-channel phased array head coil.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="neither"> Subjects were scanned in a supine, head-first position with symmetrically placed cushions on both sides of the head to decrease motion. Ear plugs were used to reduce the noise. Subjects were instructed to relax with their eyes closed but remain awake for the duration of the scanning session.</citation_analysis></p>
          <p><citation_analysis attribute="neither">Routine axial T1-weighted fluid attenuation inversion recovery (T1 Flair) [repetition time (TR) = 1750 ms, echo-time (TE) = 24 ms, numbers of excitation (NEX) = 1, field of view (FOV) = 24×24 cm, matrix = 320 × 256, slice thickness = 5 mm, gap = 1.5 mm, acquisition time = 1 min and 22 sec] and fast spin echo T2 -weighted images (T2WI) [TR = 8400 ms, TE = 145 ms, NEX = 1, FOV = 24×24 cm, matrix = 256 × 256, slice thickness = 5 mm, gap = 1.5 mm, acquisition time = 2 min and 15 sec] were obtained for anatomical localization and excluding any anatomic abnormalities including any brain tumors, vascular disease, and other cerebral illnesses.</citation_analysis></p>
          <p><citation_analysis attribute="positive">The spectra were acquired using a 2D multi-voxel technique. The volume of interest (VOI) was placed in a uniform manner by the same investigator, a trained radiologist who was blinded to the diagnosis of each participant. </citation_analysis><citation_analysis attribute="positive"><xref rid="f0002" ref-type="fig">Figure2</xref></citation_analysis><citation_analysis attribute="neither"> shows the locations of the bilateral putamen, which were determined based on anatomical localization acquired by axial T2WI (TR = 3500 ms, TE = 102 ms, NEX = 2, FOV = 24×24 cm, spatial matrix = 256 × 256, slice thickness = 5 mm without a gap, acquisition time = 1 min and 45s), VOI, and the voxels. The MRS acquisition parameters were as follows: TR = 1000ms, TE = 144ms, FOV = 24×24 cm, NEX = 2, matrix = 18 × 18, slice thickness = 10 mm, and nominal voxel size = 13×13 × 10 mm</citation_analysis><citation_analysis attribute="positive"><sup>3</sup></citation_analysis><citation_analysis attribute="neither">.
</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0002" fig-type="figure"><label>Figure 2</label><caption><p><citation_analysis attribute="neither">Examples of volume of interests (VOls) and chemical shifts for the two groups.</citation_analysis></p></caption><graphic xlink:href="NSS-16-1407-g0002" content-type="print-only" position="float"/><attrib><bold>Note</bold>: As shown in <xref rid="f0002" ref-type="fig">Figure2</xref>, the images on the left show the locations of VOls placed in the bilateral putamen for insomnia subject (<bold>A</bold>) and control subject (<bold>B</bold>). While the images on the right show the chemical shifts of metabolites including N-acetylaspartate (NAA), choline (Cho), and creatine (Cr) corresponding to the locations on the left images. The NAA, Cr, and Cho resonances spiked at 2.02 ppm, 3.02 ppm and 3.23 ppm, respectively.</attrib></fig></citation_analysis></p>
          <p><citation_analysis attribute="neither">Automatic pre-scanning was performed before each spectroscopic scan to achieve an optimal full-width half-maximum of 10 Hz. General quality standard spectra with a line width greater than 10 Hz or water suppression less than 98% efficiency were excluded. Additional saturation bands were placed outside the VOI to minimize lipid contamination from the scalp. The total acquisition time for each participant in </citation_analysis><citation_analysis attribute="positive"><sup>1</sup></citation_analysis><citation_analysis attribute="neither">H-MRS sequence was 5 min 28s.</citation_analysis></p>
        </sec>
        <sec id="s0002-s2004-s3002">
          <title>Spectral Fitting</title>
          <p><citation_analysis attribute="positive">All spectra were fitted using the automated fitting software Functool (version 9.4.05a, GE Advantage Workstation 4.5), provided by the manufacturer. The metabolite basis sets in vivo proton spectral quantitation were simulated using software developed on site.</citation_analysis></p>
        </sec>
      </sec>
      <sec id="s0002-s2005">
        <title>Statistical Analyses</title>
        <p><citation_analysis attribute="positive">Statistical analyses were performed using Statistical Package for Social Sciences (SPSS) 26.0 software. Descriptive statistics were presented as percentages for discrete variables and as means (standard deviations) for continuous variables. The Shapiro–Wilk test was used to assess whether the data were normally distributed. Chi-square test and independent-samples </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">t</italic></citation_analysis><citation_analysis attribute="neither">-test or paired-samples </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">t</italic></citation_analysis><citation_analysis attribute="neither">-test were used to compare the differences in demographic factors, scores of psychometric assessments, PSG parameters, and metabolites measured by </citation_analysis><citation_analysis attribute="positive"><sup>1</sup></citation_analysis><citation_analysis attribute="positive">H-MRS between the insomnia and control groups, where appropriate. Multivariate Analysis of Covariance (MANCOVA) was used to study the differences in bilateral putaminal metabolites between the two groups, with adjustment for sex, age, BMI, education, occupation, and total scores of SAI, TAI, and BDI-II. A partial correlation analysis was conducted to analyze the associations between putaminal metabolites and sleep parameters after controlling for sex, age, BMI, education, and occupation. Receiver operating characteristic (ROC) curve analysis was performed to explore the role of putaminal metabolites in distinguishing insomnia disorder from normal sleep. A </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> value less than 0.05 was considered statistically significant.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Results</title>
      <sec id="s0003-s2001">
        <title>Sociodemographics and Clinical Characteristics</title>
        <p><citation_analysis attribute="positive">As shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">Figure 1</xref></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">, we enrolled 23 patients with insomnia disorder (65.2% female; mean [S.D.] age, 31.3 [8.1] years; mean [S.D.] BMI, 20.7 [2.1] kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither">; mean [S.D.] education, 15.4 [3.4] years; 91.3% employee/student) from 195 individuals with insomnia complaints. Similarly, we enrolled 18 age-sex-education-nationality matched healthy normal sleepers (55.6% female; mean [S.D.] age, 28.2 [6.9] years; mean [S.D.] BMI, 21.1 [2.7] kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither">; mean [S.D.] education, 14.9 [2.3] years; 94.4% employee/student) who served as the control group from 50 individuals without insomnia complaints and medical history.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0001"><label>Table 1</label><caption><p><citation_analysis attribute="neither">Demographic, Clinical and Sleep Characteristics of the Two Groups</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Insomnia Group (n = 23)</th><th rowspan="1" colspan="1">Control Group (n = 18)</th><th rowspan="1" colspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Sex (Female, %)</td><td rowspan="1" colspan="1">15 (65.2)</td><td rowspan="1" colspan="1">10 (55.6)</td><td rowspan="1" colspan="1">0.529</td></tr><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">31.3 ± 8.1</td><td rowspan="1" colspan="1">28.2 ± 6.9</td><td rowspan="1" colspan="1">0.203</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">20.7 ± 2.1</td><td rowspan="1" colspan="1">21.1 ± 2.7</td><td rowspan="1" colspan="1">0.623</td></tr><tr><td rowspan="1" colspan="1">Education (years)</td><td rowspan="1" colspan="1">15.4 ± 3.4</td><td rowspan="1" colspan="1">14.9 ± 2.3</td><td rowspan="1" colspan="1">0.558</td></tr><tr><td rowspan="1" colspan="1">Occupation (Employee/Student, %)</td><td rowspan="1" colspan="1">21 (91.3)</td><td rowspan="1" colspan="1">17 (94.4)</td><td rowspan="1" colspan="1">0.513</td></tr><tr><td rowspan="1" colspan="1">PSQI total score</td><td rowspan="1" colspan="1">12.0 ± 2.9</td><td rowspan="1" colspan="1">3.6 ± 1.7</td><td rowspan="1" colspan="1"><bold>&lt; 0.001</bold></td></tr><tr><td rowspan="1" colspan="1">ISI total score</td><td rowspan="1" colspan="1">17.0 ± 4.6</td><td rowspan="1" colspan="1">3.1 ± 3.8</td><td rowspan="1" colspan="1"><bold>&lt; 0.001</bold></td></tr><tr><td rowspan="1" colspan="1">SAI total score</td><td rowspan="1" colspan="1">45.3 ± 11.2</td><td rowspan="1" colspan="1">32.5 ± 10.0</td><td rowspan="1" colspan="1"><bold>&lt; 0.001</bold></td></tr><tr><td rowspan="1" colspan="1">TAI total score</td><td rowspan="1" colspan="1">47.1 ± 12.2</td><td rowspan="1" colspan="1">33.6 ± 8.4</td><td rowspan="1" colspan="1"><bold>&lt; 0.001</bold></td></tr><tr><td rowspan="1" colspan="1">BDI-II total score</td><td rowspan="1" colspan="1">11.6 ± 6.0</td><td rowspan="1" colspan="1">3.7 ± 3.8</td><td rowspan="1" colspan="1"><bold>&lt; 0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Sleep onset latency (min)</td><td rowspan="1" colspan="1">35.1 ± 14.1</td><td rowspan="1" colspan="1">12.3 ± 9.2</td><td rowspan="1" colspan="1"><bold>&lt; 0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Sleep efficiency (%)</td><td rowspan="1" colspan="1">77.3 ± 11.3</td><td rowspan="1" colspan="1">87.6 ± 5.2</td><td rowspan="1" colspan="1"><bold>0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Total sleep time (min)</td><td rowspan="1" colspan="1">388.2 ± 51.8</td><td rowspan="1" colspan="1">421.7 ± 60.6</td><td rowspan="1" colspan="1">0.063</td></tr><tr><td rowspan="1" colspan="1">Awake time after sleep onset (min)</td><td rowspan="1" colspan="1">82.5 ± 65.3</td><td rowspan="1" colspan="1">36.8 ± 20.1</td><td rowspan="1" colspan="1"><bold>0.004</bold></td></tr><tr><td rowspan="1" colspan="1">Arousal index (/h)</td><td rowspan="1" colspan="1">18.5 ± 7.5</td><td rowspan="1" colspan="1">9.5 ± 3.9</td><td rowspan="1" colspan="1"><bold>&lt; 0.001</bold></td></tr><tr><td rowspan="1" colspan="1">NREM sleep stage 1 (%)</td><td rowspan="1" colspan="1">10.7 ± 4.0</td><td rowspan="1" colspan="1">7.0 ± 4.1</td><td rowspan="1" colspan="1"><bold>0.006</bold></td></tr><tr><td rowspan="1" colspan="1">NREM sleep stage 2 (%)</td><td rowspan="1" colspan="1">53.1 ± 7.2</td><td rowspan="1" colspan="1">53.5 ± 5.1</td><td rowspan="1" colspan="1">0.846</td></tr><tr><td rowspan="1" colspan="1">NREM sleep stage 3 (%)</td><td rowspan="1" colspan="1">16.4 ± 6.2</td><td rowspan="1" colspan="1">21.2 ± 6.1</td><td rowspan="1" colspan="1"><bold>0.019</bold></td></tr><tr><td rowspan="1" colspan="1">REM sleep (%)</td><td rowspan="1" colspan="1">19.7 ± 3.4</td><td rowspan="1" colspan="1">18.3 ± 4.5</td><td rowspan="1" colspan="1">0.236</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: Data are presented as sample size (percentage) for categorical variables, and mean ± standard deviation for continuous variables. </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither">-values are given for the comparison of each characteristic between the insomnia group and the control group. </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither">-values ≤ 0.05 are indicated in bold.</citation_analysis></p></fn><fn id="tfn0002"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: BMI, body mass index; PSQI, Pittsburgh Sleep Quality Index; ISI, Insomnia Severity Index; SAI, State Anxiety Inventory; TAI, Trait Anxiety Inventory; BDI-II, Beck Depression Inventory (2nd edition); NREM, non-rapid eye movement; REM, rapid eye movement.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis></p>
        <p><citation_analysis attribute="positive">There were no significant differences in demographics profile between the insomnia group and the control group with regard to sex (χ</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither"> = 0.40, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.529), age (t = 1.29, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.203), BMI (t = −0.50, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.623), education (t = 0.59, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.558) and occupation (χ</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither"> = 0.43, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.513) (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
        <p><citation_analysis attribute="neither">Compared to the control group, the insomnia group displayed higher PSQI total score (12.0 ± 2.9 vs 3.6 ± 1.7, t = 11.89, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), ISI total score (17.0 ± 4.6 vs 3.1 ± 3.8, t = 10.39, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), SAI total score (45.3 ± 11.2 vs 32.5 ± 10.0, t = 3.81, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), TAI total score (47.1 ± 12.2 vs 33.6 ± 8.4, t = 4.01, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), and BDI-II total score (11.6 ± 6.0 vs 3.7 ± 3.8, t = 5.13, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001) (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
        <p><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither"> also shows the sleep parameters of all subjects measured on the second night of the laboratory PSG. The insomnia group had a significantly lower sleep efficiency (77.3 ± 11.3 vs 87.6 ± 5.2%, t = −3.85, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.001) and a lower stage 3 sleep percentage (16.4 ± 6.2 vs 21.2 ± 6.1%, t = −2.44, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.019) than the control group. The insomnia group also displayed longer sleep latency (35.1 ± 14.1 vs 12.3 ± 9.2 min, t = 5.68, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), greater awake time after sleep onset (82.5 ± 65.3 vs 36.8 ± 20.1 min, t = 3.17, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.004), greater arousal index (18.5 ± 7.5 vs 9.5 ± 3.9 per hour, t = 4.96, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), and greater stage 1 sleep percentage (10.7 ± 4.0 vs 7.0 ± 4.1%, t = 2.89, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.006) than the control group.</citation_analysis></p>
      </sec>
      <sec id="s0003-s2002">
        <title>MRS Characteristics</title>
        <p><citation_analysis attribute="neither">None of the subjects displayed any anatomical abnormalities on routine MRI.</citation_analysis></p>
        <p><citation_analysis attribute="neither">The NAA resonance spikes at 2.02 ppm, while Cr and Cho resonance spikes at 3.02 ppm and 3.23 ppm in subjects, respectively (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0002" ref-type="fig">Figure 2</xref></citation_analysis><citation_analysis attribute="neither">). Notably, altered resonance was noted in the right putamen of the subjects with insomnia disorder.</citation_analysis></p>
        <p><citation_analysis attribute="positive">We compared the differences in bilateral putaminal metabolites between the two groups and within the groups. As shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">, the results of Independent-samples </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">t</italic></citation_analysis><citation_analysis attribute="neither"> test showed that the NAA/Cr ratio of the right putamen in the insomnia group was significantly greater than that in the control group (1.69 ± 0.16 vs 1.52 ± 0.15, t = 3.46, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive"> = 0.001). Furthermore, as shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">, the results of the paired-samples </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">t</italic></citation_analysis><citation_analysis attribute="neither">-test showed that the NAA/Cr ratio of the right putamen was significantly greater than that of the left putamen in the insomnia group (1.69 ± 0.16 vs 1.45 ± 0.17, t = 5.17, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), but not in the control group (1.52 ± 0.15 vs 1.44 ± 0.19, t = 1.31, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.207).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0002"><label>Table 2</label><caption><p><citation_analysis attribute="neither">Comparison of Metabolites in Bilateral Putamen Between the Two Groups</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Metabolite</th><th rowspan="1" colspan="1">Left/Right Putamen</th><th rowspan="1" colspan="1">Insomnia Group (n=23)</th><th rowspan="1" colspan="1">Control Group (n=18)</th><th rowspan="1" colspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td rowspan="2" colspan="1">NAA/Cr</td><td rowspan="1" colspan="1">Left putamen</td><td rowspan="1" colspan="1">1.45 ± 0.17</td><td rowspan="1" colspan="1">1.44 ± 0.19</td><td rowspan="1" colspan="1">0.975</td></tr><tr><td rowspan="1" colspan="1">Right putamen</td><td rowspan="1" colspan="1">1.69 ± 0.16</td><td rowspan="1" colspan="1">1.52 ± 0.15</td><td rowspan="1" colspan="1"><bold>0.001</bold></td></tr><tr><td rowspan="2" colspan="1">Cho/Cr</td><td rowspan="1" colspan="1">Left putamen</td><td rowspan="1" colspan="1">0.76 ± 0.17</td><td rowspan="1" colspan="1">0.74 ± 0.17</td><td rowspan="1" colspan="1">0.647</td></tr><tr><td rowspan="1" colspan="1">Right putamen</td><td rowspan="1" colspan="1">0.70 ± 0.13</td><td rowspan="1" colspan="1">0.66 ± 0.13</td><td rowspan="1" colspan="1">0.364</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: Data are presented as mean ± standard deviation for continuous variables. </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither">-values are given for the comparisons of NAA/Cr and Cho/Cr between the insomnia group and the control group. </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither">-values ≤ 0.05 are indicated in bold.</citation_analysis></p></fn><fn id="tfn0004"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: NAA, N-acetylaspartate; Cho, choline; Cr, creatine.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0003"><label>Table 3</label><caption><p><citation_analysis attribute="neither">Comparison of Metabolites in Bilateral Putamen Within Each Group</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Metabolite</th><th rowspan="1" colspan="1">Group</th><th rowspan="1" colspan="1">Left Putamen</th><th rowspan="1" colspan="1">Right Putamen</th><th rowspan="1" colspan="1"><italic toggle="yes">P</italic></th></tr></thead><tbody><tr><td rowspan="2" colspan="1">NAA/Cr</td><td rowspan="1" colspan="1">Insomnia group (n=23)</td><td rowspan="1" colspan="1">1.45 ± 0.17</td><td rowspan="1" colspan="1">1.69 ± 0.16</td><td rowspan="1" colspan="1"><bold>&lt; 0.001</bold></td></tr><tr><td rowspan="1" colspan="1">Control group (n=18)</td><td rowspan="1" colspan="1">1.44 ± 0.19</td><td rowspan="1" colspan="1">1.52 ± 0.15</td><td rowspan="1" colspan="1">0.207</td></tr><tr><td rowspan="2" colspan="1">Cho/Cr</td><td rowspan="1" colspan="1">Insomnia group (n=23)</td><td rowspan="1" colspan="1">0.76 ± 0.17</td><td rowspan="1" colspan="1">0.70 ± 0.13</td><td rowspan="1" colspan="1">0.155</td></tr><tr><td rowspan="1" colspan="1">Control group (n=18)</td><td rowspan="1" colspan="1">0.74 ± 0.17</td><td rowspan="1" colspan="1">0.66 ± 0.13</td><td rowspan="1" colspan="1">0.178</td></tr></tbody></table><table-wrap-foot><fn id="tfn0005"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: Data are presented as mean ± standard deviation for continuous variables. </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither">-values are given for the comparisons of NAA/Cr and Cho/Cr within the insomnia group and within the control group. </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither">-values ≤ 0.05 are indicated in bold.</citation_analysis></p></fn><fn id="tfn0006"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: NAA, N-acetylaspartate; Cho, choline; Cr, creatine.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis></p>
        <p><citation_analysis attribute="positive">Additionally, MANCOVA was conducted to control for factors including sex, age, BMI, education, occupation, SAI total score, TAI total score, and BDI-II total score, which showed that there was only a significant group difference with regard to the NAA/Cr ratio in the right putamen (1.71 ± 0.04 vs 1.50 ± 0.05 (adjusted mean ± standard error), F = 8.633, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.006). The TAI score tended to influence the NAA/Cr ratio in the right putamen (F = 3.986, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.055).</citation_analysis></p>
        <p><citation_analysis attribute="positive">To further evaluate the significance of the right putaminal NAA/Cr ratio difference between the two groups, ROC curve analysis was used to assess the ability of this difference to distinguish insomnia disorder from normal sleep. As shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="f0003" ref-type="fig">Figure 3</xref></citation_analysis><citation_analysis attribute="neither">, the results revealed that the NAA/Cr ratio of the right putamen could distinguish insomnia disorder from normal sleep with 78.3% sensitivity and 61.1% specificity when the cut-off value was 1.57 in all subjects (area under the curve (AUC) = 0.79, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.002). ROC curve analysis was further used to determine if its efficacy varied by sex. In males, the NAA/Cr ratio of the right putamen could distinguish insomnia disorder from normal sleep with 100% sensitivity and 62.5% specificity when the cut-off value was 1.54, or with 62.5% sensitivity and 75% specificity when cut off value was 1.62 (AUC = 0.813, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.036). In females, 80% sensitivity and 60% specificity when the cut-off value was 1.57, or with 66.7% sensitivity and 70% specificity when the cut-off value was 1.64 (AUC = 0.780, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.020).
</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0003" fig-type="figure"><label>Figure 3</label><caption><p><citation_analysis attribute="neither">Results of receiver operating characteristic (ROC) curve analyses.</citation_analysis></p></caption><graphic xlink:href="NSS-16-1407-g0003" content-type="print-only" position="float"/><attrib><bold>Note</bold>: ROC curve analyses were used to establish the efficacy and the cut off value of the right putaminal NAA/Cr ratio in distinguishing insomnia disorder from normal sleep. The right putaminal NAA/Cr ratio could distinguish insomnia disorder from normal sleep with 78.3% sensitivity and 61.1% specificity when cut off value was 1.57 in all subjects (area under the curve (AUC) = 0.785, <italic toggle="yes">P</italic> = 0.002) (<bold>A</bold>); with 100% sensitivity and 62.5% specificity when cut off value was 1.54 (or with 62.5% sensitivity and 75% specificity when cut off value was 1.62) in male subjects (AUC = 0.813, <italic toggle="yes">P</italic> = 0.036) (<bold>B</bold>); with 80% sensitivity and 60% specificity when cut off value was 1.57 (or with 66.7% sensitivity and 70% specificity when cut off value was 1.64) in female subjects (AUC = 0.780, <italic toggle="yes">P</italic> = 0.020) (<bold>C</bold>), respectively.</attrib></fig></citation_analysis></p>
        <p><citation_analysis attribute="neither">The Cho/Cr ratio of bilateral putamen did not vary significantly between the two groups (0.76 ± 0.17 vs 0.74 ± 0.17, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">t</italic></citation_analysis><citation_analysis attribute="neither"> = 0.46, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.647, and 0.70 ± 0.13 vs 0.66 ± 0.13, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">t</italic></citation_analysis><citation_analysis attribute="neither"> = 0.92, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.364) (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">) or within the insomnia group (0.76 ± 0.17 vs 0.70 ± 0.13, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">t</italic></citation_analysis><citation_analysis attribute="neither"> = −1.47, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.155) (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="positive">). The ROC curve analysis also showed no significant differences with regard to the Cho/Cr ratio of the bilateral putamen between the two groups (AUC = 0.604, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.259) or within the male (AUC = 0.406, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.529) and female (AUC = 0.720, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.067) subjects.</citation_analysis></p>
      </sec>
      <sec id="s0003-s2003">
        <title>Associations Between Putaminal Metabolites and Sleep Parameters of the Subjects</title>
        <p><citation_analysis attribute="neither">After controlling for sex, age, BMI, education, occupation, SAI total score, TAI total score, and BDI-II total score, the results of the partial correlation analyses showed that the NAA/Cr ratio of the right putamen was significantly correlated with the arousal index measured by PSG (r = 0.452, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.008), the PSQI total score (r = 0.405, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.020), and the ISI total score (r = 0.439, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.011).</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0004">
      <title>Discussion</title>
      <p><citation_analysis attribute="positive">In the present study, we investigated the neurometabolites in the bilateral putaminal regions of patients with insomnia disorder and healthy normal sleepers. We found differences in the NAA/Cr ratio between the insomnia patients and the healthy controls, with a hemispherical lateralization effect in the right putamen. In particular, the NAA/Cr ratio of the right putamen positively correlated with objective and subjective insomnia severity. Additionally, robust results in discriminating insomnia disorder from normal sleep using MRS data were demonstrated.</citation_analysis></p>
      <p><citation_analysis attribute="positive">To the best of our knowledge, the present study is the first to demonstrate putaminal NAA/Cr metabolic abnormalities in patients with insomnia disorder. Important confounders such as sex, age, and BMI were controlled between the two groups, and all subjects were unmedicated and carefully screened to be free of medical illnesses and other psychiatric disorders or secondary causes of insomnia, in order to better understand the role of putaminal metabolites including NAA and Cho in insomnia.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Consistent with our hypothesis, </citation_analysis><citation_analysis attribute="positive"><sup>1</sup></citation_analysis><citation_analysis attribute="positive">H-MRS data of the present study showed a greater NAA/Cr ratio in the right putamen of patients with insomnia disorder than in healthy normal sleepers. Specifically, the NAA/Cr ratio of the right putamen was significantly and positively correlated with the arousal index measured by PSG, PSQI total score, and ISI total score, indicating that more severe insomnia was associated with more disrupted right putaminal NAA/Cr metabolism. This is consistent with previous studies that demonstrated close associations between putaminal characteristics and insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24–27</xref></citation_analysis><citation_analysis attribute="positive"> Importantly, the identified neurobiochemical marker demonstrated that insomnia without any underlying psychiatric comorbidity may be characterized by the altered NAA/Cr ratio of the putamen, which together with previous studies further confirmed the sleep-wake regulatory role of the putamen. Additionally, the identified neurobiochemical marker was independent of sex, age, BMI, educational level, occupation status, and level of anxiety and depression symptoms, which were controlled for in group comparisons. These novel findings also provide evidence that disrupted neurobiochemical metabolites of the frontostriatal circuits are associated with insomnia disorder, suggesting that these networks contribute to the neural circuitry that underlies insomnia disorder.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0051" ref-type="bibr">51</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0052" ref-type="bibr">52</xref></citation_analysis></p>
      <p><citation_analysis attribute="negative">However, it is worth noting that previous studies have revealed inconsistent putamen volume changes in individuals with insomnia, as well as variable results for the link between the characteristics of the putamen and insomnia severity. Notably, an increased NAA/Cr ratio in the right putamen of patients with insomnia disorder was observed in the present study when compared with healthy normal sleepers. As NAA/Cr is generally considered to be a marker of neuronal viability and integrity and is often used to assess neuronal density,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37–39</xref></citation_analysis><citation_analysis attribute="positive"> our findings indicate dysfunction (enhanced) of the right putamen in patients with insomnia disorder. Thus, our results support the effect of up-regulated putaminal functional status on insomnia severity, in line with its suggested role of promoting and maintaining wakefulness.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15–19</xref></citation_analysis><citation_analysis attribute="positive"> Consistent with our findings, Emamian et al reported that poor subjective and objective sleep quality is linked with greater volumes of the lateral putamen, and speculated that this might be a compensatory mechanism to dysfunction of the limbic circuits.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Based on our findings and those of other related studies, we inferred that an altered right putaminal NAA/Cr ratio is strongly linked to wakefulness (arousal) in insomnia disorder. It has been suggested that the putamen regulates arousal by inhibitory GABAergic projections to pallidum and thalamus, promoting cortical activity and wakefulness.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither"> Along the same lines, bilateral putamen lesions produced both a reduction in the amount of wakefulness and alterations in sleep-wake architecture.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15–19</xref></citation_analysis><citation_analysis attribute="positive"> Furthermore, dopamine D1 receptor-positive neurons within the dorsal striatum, where the putamen is located, has been implicated in promoting wakefulness.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0053" ref-type="bibr">53</xref></citation_analysis><citation_analysis attribute="positive"> Together these findings are consistent with our observations of greater right putaminal NAA/Cr ratio with greater severity of insomnia. Rats with core lesions in the nucleus accumbens exhibited an increase in wakefulness and a reduction in nonrapid eye movement sleep-bout duration.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15–19</xref></citation_analysis><citation_analysis attribute="positive"> This suggests that the putamen and nucleus accumbens core may play opposing roles in sleep-wake regulation. Thus, in this line, our findings support the crucial function of the putamen in promoting and maintaining wakefulness, which is consistent with the hyperarousal model of insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0054" ref-type="bibr">54</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">The putamen is highly interconnected with frontal cortical areas, which constitute important components of the frontostriatal circuits implicated in sleep-wake regulation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither"> Altered patterns of connectivity between the putamen and frontal cortical regions in insomnia patients have been observed in fMRI studies.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0055" ref-type="bibr">55–57</xref></citation_analysis><citation_analysis attribute="positive"> Therefore, our findings provide further evidence for impairments in the frontostriatal circuits correlated with insomnia disorder.</citation_analysis></p>
      <p><citation_analysis attribute="positive">Hemispheric asymmetry of the NAA/Cr ratio in the right putamen is particularly intriguing. Brain hemispheric asymmetry in structure and function has been demonstrated across a range of processes,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0058" ref-type="bibr">58</xref></citation_analysis><citation_analysis attribute="neither"> such as the neural processing of language, faces, or emotions.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0059" ref-type="bibr">59</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0060" ref-type="bibr">60</xref></citation_analysis><citation_analysis attribute="positive"> Bilateral age-related shrinkage of the putamen also shows hemispherical lateralization with a significant rightward asymmetry in the putamen and the caudate.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0061" ref-type="bibr">61</xref></citation_analysis><citation_analysis attribute="positive"> Patients with psychiatric disorders often demonstrate atypical hemispheric asymmetry.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0058" ref-type="bibr">58</xref></citation_analysis><citation_analysis attribute="neither"> This phenomenon was further confirmed by our finding of the NAA/Cr metabolism in the right putamen of patients with insomnia disorder. However, the exact mechanism linking this hemispheric asymmetry and insomnia disorder requires further investigation.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Notably, the results of the ROC curve analysis in this study revealed the cut-off value of the NAA/Cr ratio in the right putamen between insomnia and normal sleep. Taken together with other results, we suggest that the NAA/Cr ratio of the right putamen may be a potential candidate biomarker of insomnia disorder, warranting future comprehensive neurochemical profiling of the putamen. In addition, our reliance on the single-mode neuroimaging technique limited our ability to simultaneously verify potential morphological and other functional differences between the two groups.</citation_analysis></p>
      <p><citation_analysis attribute="positive">This study has several limitations that merit further discussion. First, the cross-sectional design of the study makes it unclear whether the putaminal neurochemical profile in this study is inherent to insomnia disorder or generalized to the effects of chronic sleep disturbance. Future longitudinal studies are warranted to investigate whether treatment normalizes the NAA/Cr ratio of the right putamen in patients with insomnia disorder. Second, the anatomical specificity of metabolites in all subdivided functional units of the putamen is challenging to determine using </citation_analysis><citation_analysis attribute="positive"><sup>1</sup></citation_analysis><citation_analysis attribute="neither">H-MRS. Future neuroimaging investigations, including a combination of multi-mode imaging methods, are warranted, and may yield more comprehensive and precise results. Moreover, we did not assess other neurotransmitters and metabolites such as gamma-aminobutyric acid, which has a notable role in the etiology of insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0062" ref-type="bibr">62</xref></citation_analysis><citation_analysis attribute="positive"> Third, our results were only generalizable to young and middle-aged adults with primary insomnia disorder. Evaluation of a wider age range and those with comorbid insomnia would be more instructive. Last, our data are preliminary, in that they are from a small cohort of patients with insomnia disorder, but lend further support to the growing evidence of putaminal regulation on sleep and wakefulness. Further studies with larger cohorts are warranted.</citation_analysis></p>
    </sec>
    <sec id="s0005">
      <title>Conclusion</title>
      <p><citation_analysis attribute="positive">In summary, the present study provides the first evidence of hemispherically lateralized abnormalities of NAA/Cr metabolism in the right putamen of patients with insomnia disorder, which positively correlated with objective and subjective insomnia severity. Our findings address the potential role of the right putaminal NAA/Cr metabolic abnormality in the underlying mechanism of insomnia disorder, suggesting that besides its crucial role in motor and cognitive behaviors, the putamen may also exert its regulatory influence on the sleep-wake cycle (ie, wakefulness (arousal) promotion and maintenance), which might aid in providing more evidence for elucidating the etiology and progression of insomnia disorder.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p><citation_analysis attribute="neither">We would like to express our sincere gratitude to Dr. Lingtao Zhang from the Medical Imaging Center, The First Affiliated Hospital of Jinan University, Guangzhou, China, for his invaluable assistance in the medical imaging methodology employed in our study. This encompassed providing essential images, interpreting results, addressing specific queries related to medical imaging aspects and participating in the revision of the manuscript. Furthermore, we extend our heartfelt appreciation to all the participants involved in this study.</citation_analysis></p>
      <p><citation_analysis attribute="neither">This study was funded by the Science and Technology Projects of Guangzhou, China (202201010731), and the Special Fund for Scientific Research Training of The First Clinical Medical College of Jinan University, China (2018105).</citation_analysis></p>
    </ack>
    <sec sec-type="COI-statement" id="s0006">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">The authors declare that they have no conflicts of interest in this work. All authors have read and approved the final version for publication. This article is the authors’ original work, has not been previously published, and is not under consideration for publication elsewhere.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Perlis</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Posner</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Riemann</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Insomnia</article-title>. <source><italic toggle="yes">Lancet</italic></source>. <year>2022</year>;<volume>400</volume>(<issue>10357</issue>):<fpage>1047</fpage>–<lpage>1060</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(22)00879-0</pub-id><pub-id pub-id-type="pmid">36115372</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Morin</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Jarrin</surname>
<given-names>DC</given-names></string-name>. <article-title>Epidemiology of insomnia: prevalence, course, risk factors, and public health burden</article-title>. <source><italic toggle="yes">Sleep Med Clin</italic></source>. <year>2022</year>;<volume>17</volume>(<issue>2</issue>):<fpage>173</fpage>–<lpage>191</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jsmc.2022.03.003</pub-id><pub-id pub-id-type="pmid">35659072</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Park</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Cho</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Sex differences in the association between social relationships and insomnia symptoms</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2020</year>;<volume>16</volume>(<issue>11</issue>):<fpage>1871</fpage>–<lpage>1881</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.8710</pub-id><pub-id pub-id-type="pmid">32713419</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cao</surname>
<given-names>XL</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Zhong</surname>
<given-names>BL</given-names></string-name>, et al. <article-title>The prevalence of insomnia in the general population in China: a meta-analysis</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2017</year>;<volume>12</volume>(<issue>2</issue>):<fpage>e0170772</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0170772</pub-id><pub-id pub-id-type="pmid">28234940</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kronholm</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Puusniekka</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Jokela</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Trends in self-reported sleep problems, tiredness and related school performance among Finnish adolescents from 1984 to 2011</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2015</year>;<volume>24</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>10</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.12258</pub-id><pub-id pub-id-type="pmid">25367818</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Freeman</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Sheaves</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Waite</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Sleep disturbance and psychiatric disorders</article-title>. <source><italic toggle="yes">Lancet Psychiatry</italic></source>. <year>2020</year>;<volume>7</volume>(<issue>7</issue>):<fpage>628</fpage>–<lpage>637</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2215-0366(20)30136-X</pub-id><pub-id pub-id-type="pmid">32563308</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Javaheri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Redline</surname>
<given-names>S</given-names></string-name>. <article-title>Insomnia and risk of cardiovascular disease</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2017</year>;<volume>152</volume>(<issue>2</issue>):<fpage>435</fpage>–<lpage>444</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2017.01.026</pub-id><pub-id pub-id-type="pmid">28153671</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lian</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Xiao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Associations between insomnia, sleep duration and poor work ability</article-title>. <source><italic toggle="yes">J Psychosom Res</italic></source>. <year>2015</year>;<volume>78</volume>(<issue>1</issue>):<fpage>45</fpage>–<lpage>51</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpsychores.2014.09.009</pub-id><pub-id pub-id-type="pmid">25288095</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Porosnicu Rodriguez</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Salas</surname>
<given-names>RME</given-names></string-name>, <string-name><surname>Schneider</surname>
<given-names>L</given-names></string-name>. <article-title>Insomnia: personalized diagnosis and treatment options</article-title>. <source><italic toggle="yes">Neurol Clin</italic></source>. <year>2023</year>;<volume>41</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>19</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ncl.2022.07.004</pub-id><pub-id pub-id-type="pmid">36400549</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Riemann</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Nissen</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Palagini</surname>
<given-names>L</given-names></string-name>, et al. <article-title>The neurobiology, investigation, and treatment of chronic insomnia</article-title>. <source><italic toggle="yes">Lancet Neurol</italic></source>. <year>2015</year>;<volume>14</volume>(<issue>5</issue>):<fpage>547</fpage>–<lpage>558</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(15)00021-6</pub-id><pub-id pub-id-type="pmid">25895933</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chassain</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Cladiere</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tsoutsos</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Glutamate cycle changes in the putamen of patients with de novo Parkinson’s disease using 1H MRS</article-title>. <source><italic toggle="yes">Parkinsonism Relat Disord</italic></source>. <year>2022</year>;<volume>99</volume>:<fpage>65</fpage>–<lpage>72</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.parkreldis.2022.05.007</pub-id><pub-id pub-id-type="pmid">35613535</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yuan</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Striato-cortical tracts predict 12-h abstinence-induced lapse in smokers</article-title>. <source><italic toggle="yes">Neuropsychopharmacology</italic></source>. <year>2018</year>;<volume>43</volume>(<issue>12</issue>):<fpage>2452</fpage>–<lpage>2458</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41386-018-0182-x</pub-id><pub-id pub-id-type="pmid">30131564</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Arsalidou</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Duerden</surname>
<given-names>EG</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>MJ</given-names></string-name>. <article-title>The centre of the brain: topographical model of motor, cognitive, affective, and somatosensory functions of the basal ganglia</article-title>. <source><italic toggle="yes">Hum Brain Mapp</italic></source>. <year>2013</year>;<volume>34</volume>(<issue>11</issue>):<fpage>3031</fpage>–<lpage>3054</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hbm.22124</pub-id><pub-id pub-id-type="pmid">22711692</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="book"><string-name><surname>Koziol</surname>
<given-names>LF</given-names></string-name>, <string-name><surname>Budding</surname>
<given-names>DE</given-names></string-name>. <source><italic toggle="yes">Subcortical Structures and Cognition: Implications for Neuropsychological Assessment</italic></source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2009</year>.</mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Qiu</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Vetrivelan</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Fuller</surname>
<given-names>PM</given-names></string-name>, et al. <article-title>Basal ganglia control of sleep-wake behavior and cortical activation</article-title>. <source><italic toggle="yes">Eur J Neurosci</italic></source>. <year>2010</year>;<volume>31</volume>(<issue>3</issue>):<fpage>499</fpage>–<lpage>507</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1460-9568.2009.07062.x</pub-id><pub-id pub-id-type="pmid">20105243</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Vetrivelan</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Qiu</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Role of basal ganglia in sleep-wake regulation: neural circuitry and clinical significance</article-title>. <source><italic toggle="yes">Front Neuroanat</italic></source>. <year>2010</year>;<volume>4</volume>:<fpage>145</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnana.2010.00145</pub-id><pub-id pub-id-type="pmid">21151379</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mena-Segovia</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Cintra</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Prospéro-García</surname>
<given-names>O</given-names></string-name>, et al. <article-title>Changes in sleep-waking cycle after striatal excitotoxic lesions</article-title>. <source><italic toggle="yes">Behav Brain Res</italic></source>. <year>2002</year>;<volume>136</volume>(<issue>2</issue>):<fpage>475</fpage>–<lpage>481</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0166-4328(02)00201-2</pub-id><pub-id pub-id-type="pmid">12429410</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lazarus</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>ZL</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>J</given-names></string-name>, et al. <article-title>How do the basal ganglia regulate sleep-wake behavior?</article-title>
<source><italic toggle="yes">Trends Neurosci</italic></source>. <year>2012</year>;<volume>35</volume>(<issue>12</issue>):<fpage>723</fpage>–<lpage>732</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tins.2012.07.001</pub-id><pub-id pub-id-type="pmid">22858523</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hasegawa</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Selway</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gnoni</surname>
<given-names>V</given-names></string-name>, et al. <article-title>The subcortical belly of sleep: new possibilities in neuromodulation of basal ganglia?</article-title>
<source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2020</year>;<volume>52</volume>:<fpage>101317</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2020.101317</pub-id><pub-id pub-id-type="pmid">32446196</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Emamian</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Mahdipour</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Noori</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Alterations of subcortical brain structures in paradoxical and psychophysiological insomnia disorder</article-title>. <source><italic toggle="yes">Front Psychiatry</italic></source>. <year>2021</year>;<volume>12</volume>:<fpage>661286</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyt.2021.661286</pub-id><pub-id pub-id-type="pmid">34025484</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Falgàs</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Illán-Gala</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Allen</surname>
<given-names>IE</given-names></string-name>, et al. <article-title>Specific cortical and subcortical grey matter regions are associated with insomnia severity</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2021</year>;<volume>16</volume>(<issue>5</issue>):<fpage>e0252076</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0252076</pub-id><pub-id pub-id-type="pmid">34038462</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Grau-Rivera</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Operto</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Falcón</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adults</article-title>. <source><italic toggle="yes">Alzheimers Res Ther</italic></source>. <year>2020</year>;<volume>12</volume>(<issue>1</issue>):<fpage>4</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13195-019-0547-3</pub-id><pub-id pub-id-type="pmid">31907066</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Abnormalities of thalamus volume and resting state functional connectivity in primary insomnia patients</article-title>. <source><italic toggle="yes">Brain Imaging Behav</italic></source>. <year>2019</year>;<volume>13</volume>(<issue>5</issue>):<fpage>1193</fpage>–<lpage>1201</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11682-018-9932-y</pub-id><pub-id pub-id-type="pmid">30091019</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Koo</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>Shin</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Lim</surname>
<given-names>JS</given-names></string-name>, et al. <article-title>Changes in subcortical shape and cognitive function in patients with chronic insomnia</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2017</year>;<volume>35</volume>:<fpage>23</fpage>–<lpage>26</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2017.04.002</pub-id><pub-id pub-id-type="pmid">28619178</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lu</surname>
<given-names>FM</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>SL</given-names></string-name>, et al. <article-title>Disrupted topology of frontostriatal circuits is linked to the severity of insomnia</article-title>. <source><italic toggle="yes">Front Neurosci</italic></source>. <year>2017</year>;<volume>11</volume>:<fpage>214</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnins.2017.00214</pub-id><pub-id pub-id-type="pmid">28469552</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Motomura</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Katsunuma</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ayabe</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Decreased activity in the reward network of chronic insomnia patients</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2021</year>;<volume>11</volume>(<issue>1</issue>):<fpage>3600</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-020-79989-2</pub-id><pub-id pub-id-type="pmid">33574355</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sanz-Arigita</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Daviaux</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Joliot</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Brain reactivity to humorous films is affected by insomnia</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2021</year>;<volume>44</volume>(<issue>9</issue>):<fpage>zsab081</fpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/zsab081</pub-id><pub-id pub-id-type="pmid">33772591</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zou</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Altered thalamic connectivity in insomnia disorder during wakefulness and sleep</article-title>. <source><italic toggle="yes">Hum Brain Mapp</italic></source>. <year>2021</year>;<volume>42</volume>(<issue>1</issue>):<fpage>259</fpage>–<lpage>270</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hbm.25221</pub-id><pub-id pub-id-type="pmid">33048406</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shao</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Dysfunction of the NAc-mPFC circuit in insomnia disorder</article-title>. <source><italic toggle="yes">Neuroimage Clin</italic></source>. <year>2020</year>;<volume>28</volume>:<fpage>102474</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nicl.2020.102474</pub-id><pub-id pub-id-type="pmid">33395968</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bell-McGinty</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Habeck</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Hilton</surname>
<given-names>HJ</given-names></string-name>, et al. <article-title>Identification and differential vulnerability of a neural network in sleep deprivation</article-title>. <source><italic toggle="yes">Cereb Cortex</italic></source>. <year>2004</year>;<volume>14</volume>(<issue>5</issue>):<fpage>496</fpage>–<lpage>502</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cercor/bhh011</pub-id><pub-id pub-id-type="pmid">15054065</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Brain iron deposition in primary insomnia-An in vivo susceptibility-weighted imaging study</article-title>. <source><italic toggle="yes">Brain Behav</italic></source>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>e01138</fpage>. doi:<pub-id pub-id-type="doi">10.1002/brb3.1138</pub-id><pub-id pub-id-type="pmid">30548431</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Suzuki</surname>
<given-names>K</given-names></string-name>. <article-title>Current update on clinically relevant sleep issues in Parkinson’s disease: a narrative review</article-title>. <source><italic toggle="yes">J Parkinsons Dis</italic></source>. <year>2021</year>;<volume>11</volume>(<issue>3</issue>):<fpage>971</fpage>–<lpage>992</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JPD-202425</pub-id><pub-id pub-id-type="pmid">33896849</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lajoie</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Lafontaine</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Kaminska</surname>
<given-names>M</given-names></string-name>. <article-title>The spectrum of sleep disorders in Parkinson disease: a review</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2021</year>;<volume>159</volume>(<issue>2</issue>):<fpage>818</fpage>–<lpage>827</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2020.09.099</pub-id><pub-id pub-id-type="pmid">32956712</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wilson</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Giordano</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Turkheimer</surname>
<given-names>FE</given-names></string-name>, et al. <article-title>Serotonergic dysregulation is linked to sleep problems in Parkinson’s disease</article-title>. <source><italic toggle="yes">Neuroimage Clin</italic></source>. <year>2018</year>;<volume>18</volume>:<fpage>630</fpage>–<lpage>637</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nicl.2018.03.001</pub-id><pub-id pub-id-type="pmid">29845011</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Saade-Lemus</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Videnovic</surname>
<given-names>A</given-names></string-name>. <article-title>Sleep disorders and circadian disruption in huntington’s disease</article-title>. <source><italic toggle="yes">J Huntingtons Dis</italic></source>. <year>2023</year>;<volume>12</volume>(<issue>2</issue>):<fpage>121</fpage>–<lpage>131</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JHD-230576</pub-id><pub-id pub-id-type="pmid">37424473</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wiegand</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Möller</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Lauer</surname>
<given-names>CJ</given-names></string-name>, et al. <article-title>Nocturnal sleep in huntington’s disease</article-title>. <source><italic toggle="yes">J Neurol</italic></source>. <year>1991</year>;<volume>238</volume>(<issue>4</issue>):<fpage>203</fpage>–<lpage>208</lpage>. doi:<pub-id pub-id-type="doi">10.1007/BF00314781</pub-id><pub-id pub-id-type="pmid">1832711</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bertholdo</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Watcharakorn</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Castillo</surname>
<given-names>M</given-names></string-name>. <article-title>Brain proton magnetic resonance spectroscopy: introduction and overview</article-title>. <source><italic toggle="yes">Neuroimaging Clin N Am</italic></source>. <year>2013</year>;<volume>23</volume>(<issue>3</issue>):<fpage>359</fpage>–<lpage>380</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nic.2012.10.002</pub-id><pub-id pub-id-type="pmid">23928194</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Paslakis</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Träber</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Roberz</surname>
<given-names>J</given-names></string-name>, et al. <article-title>N-acetyl-aspartate (NAA) as a correlate of pharmacological treatment in psychiatric disorders: a systematic review</article-title>. <source><italic toggle="yes">Eur Neuropsychopharmacol</italic></source>. <year>2014</year>;<volume>24</volume>(<issue>10</issue>):<fpage>1659</fpage>–<lpage>1675</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.euroneuro.2014.06.004</pub-id><pub-id pub-id-type="pmid">25130303</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Clark</surname>
<given-names>JB</given-names></string-name>. <article-title>N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction</article-title>. <source><italic toggle="yes">Dev Neurosci</italic></source>. <year>1998</year>;<volume>20</volume>(<issue>4–5</issue>):<fpage>271</fpage>–<lpage>276</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000017321</pub-id><pub-id pub-id-type="pmid">9778562</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Riley</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Renshaw</surname>
<given-names>PF</given-names></string-name>. <article-title>Brain choline in major depression: a review of the literature</article-title>. <source><italic toggle="yes">Psychiatry Res Neuroimaging</italic></source>. <year>2018</year>;<volume>271</volume>:<fpage>142</fpage>–<lpage>153</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pscychresns.2017.11.009</pub-id><pub-id pub-id-type="pmid">29174766</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dhamala</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Abdelkefi</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Nguyen</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Validation of in vivo MRS measures of metabolite concentrations in the human brain</article-title>. <source><italic toggle="yes">NMR Biomed</italic></source>. <year>2019</year>;<volume>32</volume>(<issue>3</issue>):<fpage>e4058</fpage>. doi:<pub-id pub-id-type="doi">10.1002/nbm.4058</pub-id><pub-id pub-id-type="pmid">30663818</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sheehan</surname>
<given-names>DV</given-names></string-name>, <string-name><surname>Lecrubier</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Sheehan</surname>
<given-names>KH</given-names></string-name>, et al. <article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title>. <source><italic toggle="yes">J Clin Psychiatry</italic></source>. <year>1998</year>;<volume>59</volume>(<issue>Suppl 20</issue>):<fpage>22</fpage>–<lpage>33</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Si</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Shu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Dang</surname>
<given-names>WM</given-names></string-name>, et al. <article-title>Evaluation of the reliability and validity of Chinese version of the mini-international neuropsychiatric interview in patients with mental disorders</article-title>. <source><italic toggle="yes">Chin Ment Health J</italic></source>. <year>2009</year>;<volume>23</volume>(<issue>0z1</issue>):<fpage>30</fpage>–<lpage>36</lpage>. doi:<pub-id pub-id-type="doi">10.3969/j.issn.1000-6729.2009.07.011</pub-id></mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Huang</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Plasma neuropeptide Y levels in Chinese patients with primary insomnia</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2015</year>;<volume>19</volume>(<issue>2</issue>):<fpage>617</fpage>–<lpage>622</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-014-1059-9</pub-id><pub-id pub-id-type="pmid">25260689</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Buysse</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Reynolds</surname>
<given-names>CF</given-names></string-name>, <string-name><surname>Monk</surname>
<given-names>TH</given-names></string-name>, et al. <article-title>The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research</article-title>. <source><italic toggle="yes">Psychiatry Res</italic></source>. <year>1989</year>;<volume>28</volume>(<issue>2</issue>):<fpage>193</fpage>–<lpage>213</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0165-1781(89)90047-4</pub-id><pub-id pub-id-type="pmid">2748771</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Serum zonula occludens-1 and claudin-5 levels in patients with insomnia disorder: a pilot study</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2023</year>;<volume>15</volume>:<fpage>873</fpage>–<lpage>884</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S424756</pub-id><pub-id pub-id-type="pmid">37928369</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Morin</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Belleville</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Bélanger</surname>
<given-names>L</given-names></string-name>, et al. <article-title>The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2011</year>;<volume>34</volume>(<issue>5</issue>):<fpage>601</fpage>–<lpage>608</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/34.5.601</pub-id><pub-id pub-id-type="pmid">21532953</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0048">
        <label>48.</label>
        <mixed-citation publication-type="book"><string-name><surname>Spielberger</surname>
<given-names>CD</given-names></string-name>, <string-name><surname>Gorsuch</surname>
<given-names>RL</given-names></string-name>. <source><italic toggle="yes">Manual for the State-Trait Anxiety Inventory (Form Y) (”Self-Evaluation Questionnaire”)</italic></source>. <publisher-name>Consulting Psychologists Press</publisher-name>; <year>1983</year>.</mixed-citation>
      </ref>
      <ref id="cit0049">
        <label>49.</label>
        <mixed-citation publication-type="book"><string-name><surname>Beck</surname>
<given-names>AT</given-names></string-name>, <string-name><surname>Steer</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Brown</surname>
<given-names>GK</given-names></string-name>. <source><italic toggle="yes">Manual for the Beck Depression Inventory-II</italic></source>. <publisher-loc>San Antonio, TX</publisher-loc>: <publisher-name>Psychological Corporation</publisher-name>; <year>1996</year>.</mixed-citation>
      </ref>
      <ref id="cit0050">
        <label>50.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lai</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhong</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>X</given-names></string-name>, et al. <article-title>Biochemical abnormalities in basal ganglia and executive dysfunction in acute- and euthymic-episode patients with bipolar disorder: a proton magnetic resonance spectroscopy study</article-title>. <source><italic toggle="yes">J Affect Disord</italic></source>. <year>2018</year>;<volume>225</volume>:<fpage>108</fpage>–<lpage>116</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2017.07.036</pub-id><pub-id pub-id-type="pmid">28818755</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0051">
        <label>51.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Response inhibition impairment related to altered frontal-striatal functional connectivity in insomnia disorder: a pilot and non-clinical study</article-title>. <source><italic toggle="yes">J Psychiatr Res</italic></source>. <year>2024</year>;<volume>170</volume>:<fpage>138</fpage>–<lpage>146</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpsychires.2023.12.023</pub-id><pub-id pub-id-type="pmid">38134723</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0052">
        <label>52.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Shao</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Disrupted frontostriatal connectivity in primary insomnia: a DTI study</article-title>. <source><italic toggle="yes">Brain Imaging Behav</italic></source>. <year>2021</year>;<volume>15</volume>(<issue>5</issue>):<fpage>2524</fpage>–<lpage>2531</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11682-021-00454-3</pub-id><pub-id pub-id-type="pmid">33651331</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0053">
        <label>53.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dong</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>ZK</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Striatal neurons expressing dopamine D1 receptor promote wakefulness in mice</article-title>. <source><italic toggle="yes">Curr Biol</italic></source>. <year>2022</year>;<volume>32</volume>(<issue>3</issue>):<fpage>600</fpage>–<lpage>613.e4</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2021.12.026</pub-id><pub-id pub-id-type="pmid">35021048</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0054">
        <label>54.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dressle</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Riemann</surname>
<given-names>D</given-names></string-name>. <article-title>Hyperarousal in insomnia disorder: current evidence and potential mechanisms</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2023</year>;<volume>32</volume>(<issue>6</issue>):<fpage>e13928</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.13928</pub-id><pub-id pub-id-type="pmid">37183177</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0055">
        <label>55.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Altered long- and short-range functional connectivity density associated with poor sleep quality in patients with chronic insomnia disorder: a resting-state fMRI study</article-title>. <source><italic toggle="yes">Brain Behav</italic></source>. <year>2020</year>;<volume>10</volume>(<issue>11</issue>):<fpage>e01844</fpage>. doi:<pub-id pub-id-type="doi">10.1002/brb3.1844</pub-id><pub-id pub-id-type="pmid">32935924</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0056">
        <label>56.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zou</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Shao</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Sleep discrepancy is associated with alterations in the salience network in patients with insomnia disorder: an EEG-fMRI study</article-title>. <source><italic toggle="yes">Neuroimage Clin</italic></source>. <year>2022</year>;<volume>35</volume>:<fpage>103111</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nicl.2022.103111</pub-id><pub-id pub-id-type="pmid">35863180</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0057">
        <label>57.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Guo</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Shao</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Thalamic network under wakefulness after sleep onset and its coupling with daytime fatigue in insomnia disorder: an EEG-fMRI study</article-title>. <source><italic toggle="yes">J Affect Disord</italic></source>. <year>2023</year>;<volume>334</volume>:<fpage>92</fpage>–<lpage>99</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2023.04.100</pub-id><pub-id pub-id-type="pmid">37149048</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0058">
        <label>58.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mundorf</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ocklenburg</surname>
<given-names>S</given-names></string-name>. <article-title>Hemispheric asymmetries in mental disorders: evidence from rodent studies</article-title>. <source><italic toggle="yes">J Neural Transm</italic></source>. <year>2023</year>;<volume>130</volume>(<issue>9</issue>):<fpage>1153</fpage>–<lpage>1165</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00702-023-02610-z</pub-id><pub-id pub-id-type="pmid">36842091</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0059">
        <label>59.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ocklenburg</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mundorf</surname>
<given-names>A</given-names></string-name>. <article-title>Symmetry and asymmetry in biological structures</article-title>. <source><italic toggle="yes">Proc Natl Acad Sci</italic></source>. <year>2022</year>;<volume>119</volume>(<issue>28</issue>):<fpage>e2204881119</fpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.2204881119</pub-id><pub-id pub-id-type="pmid">35787037</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0060">
        <label>60.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Corballis</surname>
<given-names>MC</given-names></string-name>. <article-title>Evolution of cerebral asymmetry</article-title>. <source><italic toggle="yes">Prog Brain Res</italic></source>. <year>2019</year>;<volume>250</volume>:<fpage>153</fpage>–<lpage>178</lpage>. doi:<pub-id pub-id-type="doi">10.1016/bs.pbr.2019.04.041</pub-id><pub-id pub-id-type="pmid">31703900</pub-id>
</mixed-citation>
      </ref>
      <ref id="cit0061">
        <label>61.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Abedelahi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hasanzadeh</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Hadizadeh</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Morphometric and volumetric study of caudate and putamen nuclei in normal individuals by MRI: effect of normal aging, gender and hemispheric differences</article-title>. <source><italic toggle="yes">Pol J Radiol</italic></source>. <year>2013</year>;<volume>78</volume>(<issue>3</issue>):<fpage>7</fpage>–<lpage>14</lpage>. doi:<pub-id pub-id-type="doi">10.12659/PJR.889364</pub-id></mixed-citation>
      </ref>
      <ref id="cit0062">
        <label>62.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schneider</surname>
<given-names>L</given-names></string-name>. <article-title>Neurobiology and neuroprotective benefits of sleep</article-title>. <source><italic toggle="yes">Continuum</italic></source>. <year>2020</year>;<volume>26</volume>(<issue>4</issue>):<fpage>848</fpage>–<lpage>870</lpage>. doi:<pub-id pub-id-type="doi">10.1212/CON.0000000000000878</pub-id><pub-id pub-id-type="pmid">32756225</pub-id>
</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
